Tetrahydro-11-deoxy cortisol
CAS: 68-60-0
Ref. 3D-FT28089
2mg | 136,00 € | ||
5mg | 206,00 € | ||
10mg | 330,00 € | ||
25mg | 560,00 € | ||
50mg | 902,00 € |
Información del producto
- (3α,5β)-3,17,21-Trihydroxypregnan-20-one5β-Pregnane-3α,17α,21-triol-20-one
- (3Alpha,5Beta)-3,17,21-Trihydroxypregnan-20-One
- (3α,5β)-3,17,21-Trihydroxypregnan-20-one
- 11-Deoxytetrahydrocortisol
- 3,17,21-Trihydroxypregnan-20-One
- 3alpha,17,21-Trihydroxy-5beta-pregnan-20-one
- 3α,17,21-Trihydroxy-5β-pregnan-20-one
- 3α,17α,21-Trihydroxy-5β-pregnan-20-one
- 3α,17α,21-Trihydroxy-5β-pregnane-20-one
- 5β-Pregnan-20-one, 3α,17,21-trihydroxy-
- Ver más sinónimos
- Cortexolone, tetrahydro-
- Cortisol, 11-deoxytetrahydro-
- Nsc 53901
- Pregnan-20-one, 3,17,21-trihydroxy-, (3alpha,5beta)-
- Pregnan-20-one, 3,17,21-trihydroxy-, (3α,5β)-
- Reichstein's substance S, tetrahydro-
- Tetrahydro S
- Tetrahydro-11-deoxy-17α-hydroxycorticosterone
- Tetrahydro-11-deoxycortisol
- Tetrahydro-11-desoxycortisol
- Tetrahydro-17-hydroxy-11-deoxycorticosterone
- Tetrahydrocortexolone
- Tetrahydrodeoxycortisol
Tetrahydro-11-deoxy cortisol (THDOC) is a synthetic corticosteroid that is used in the treatment of proliferative diabetic retinopathy. It has been shown to reduce the severity of retinal neovascularization in experimental models. THDOC has a hydroxyl group at position 11 and a double bond between C-11 and C-12, which are not present in natural cortisol. The body mass index (BMI) of women with high values for THDOC is correlated with the prevalence of adrenocortical carcinoma. This correlation suggests that THDOC may be useful as a diagnostic marker for this type of cancer.
Propiedades químicas
Consulta técnica sobre: 3D-FT28089 Tetrahydro-11-deoxy cortisol
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.